Loading clinical trials...
Loading clinical trials...
Introduction: Staphylococcus aureus bacteremia (SAB) plays an important role in long-course antibiotic therapy. Current international guidelines recommend fourteen days of intravenous antibiotic treat...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Thomas Benfield
NCT06650501 · Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia, and more
NCT05137119 · Staphylococcus Aureus Bacteremia
NCT06574399 · Staphylococcus Aureus Bacteremia
NCT06336824 · Staphylococcus Aureus Bacteremia
NCT06695832 · Staphylococcus Aureus Bacteremia
Hvidovre Hospital
Hvidovre, Copenhagen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions